ArtsAutosBooksBusinessEducationEntertainmentFamilyFashionFoodGamesGenderHealthHolidaysHomeHubPagesPersonal FinancePetsPoliticsReligionSportsTechnologyTravel
  • »
  • Politics and Social Issues»
  • Crime & Law Enforcement


Updated on May 19, 2009

Purdue Pharma Guilty of Criminal Misbranding

Purdue Pharma pleaded guilty to federal criminal charges and will pay $600 million in fines and other charges. Three executives also pleaded guilty to criminal charges and will pay $64 million in fines for supplying misleading information regarding the addictive characteristics of their painkiller, Oxycontin. This is one of the largest fines ever levied against a pharmaceutical company. Here's a link to a NY Times article on the criminal case.

Howard R. Udell, Purdue's top lawyer, Dr. Paul Goldenheim, Medical Director, Michael Friedman, President


    0 of 8192 characters used
    Post Comment

    • Ralph Deeds profile image

      Ralph Deeds 7 years ago from Birmingham, Michigan

      So true. Lock 'em up and throw away the key.

    • profile image

      Iðunn 7 years ago

      Every time I see the word oxycontin I think of Rush Limbaugh. I think that connection might make a lot of would-be addicts think twice just to avoid the association and mental image of his plug-ugly face. :p

      Iskra, until Limbaugh was busted and during the time he was addicted and using illegally, he was bashing the poorer type addicts and saying they should be locked up for life. The hypocrisy was astounding.

      Notice when it was him caught, he had a different view entirely. His case was "special". Narcissists.

    • iskra1916 profile image

      iskra1916 7 years ago from Belfast, Ireland.

      These super-elite hawkers of hillbilly heroin should be locked up in Federal prison for their perfidy.

    • Ralph Deeds profile image

      Ralph Deeds 8 years ago from Birmingham, Michigan

      Great idea!

    • profile image 8 years ago

      Big Pharma should be required to donate one-half-of-one-percent of revenue to emergency humanitarian aid organizations, such as Doctors Without Borders. The shareholders should demand it.